Newsfile Corp
21 Sept 2026, 15:41 UTC · 2h ago
Verdict
Headline leans bearish. We score GUTS −1.00 across two claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
Investors have until October 20, 2026, to seek the role of lead plaintiff in a federal securities class action lawsuit against Fractyl Health.
NewNewsfile Corp. report dated September 21, 2026
More negative than 71% of claims this week
The class action complaint alleges Fractyl misled investors regarding Revita's effectiveness and that operational issues at clinical sites compromised the REMAIN-1 Midpoint Cohort results.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
So whatThe underlying clinical failure already wiped out ~89% of the share price between Jan 29 and Jan 30, 2026.
More negative than 67% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a federal securities class action lawsuit and significant stock price declines following allegations of misleading statements about its Revita treatment.
Near neutral — 90% of ticker scores this week are stronger
Morgan Stanley is mentioned only as a source of a report and rating downgrade for Fractyl.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
2h ago
−2.5%
Price agrees with the score
$0.5851 vs $0.6000 close before publication (Sep 18) · not market-adjusted
GUTS chart →